Axogen, Inc. Additional Paid in Capital, Common Stock
Axogen, Inc. (AXGN) had Additional Paid in Capital, Common Stock of $583.78 million as of 2026-06-30, per its 10-Q filed 2026-07-29.
Financial Statements › Balance Sheet › Equity › Equity, Attributable to Parent
us-gaap:AdditionalPaidInCapitalCommonStock · last filed 2026-07-29
- 2026-06-30: Additional Paid in Capital, Common Stock $583.78M.
- 2026-03-31: Additional Paid in Capital, Common Stock $570.82M.
- 2025-12-31: Additional Paid in Capital, Common Stock $435.34M.
- 2025-09-30: Additional Paid in Capital, Common Stock $414.15M.
| Period end | Additional Paid in Capital, Common Stock | Additional Paid in Capital, Common Stock as first filed |
|---|---|---|
| 2026-06-30 | $583.78M 10-Q · filed 2026-07-29 | |
| 2026-03-31 | $570.82M 10-Q · filed 2026-04-28 | |
| 2025-12-31 | $435.34M 10-Q · filed 2026-07-29 | |
| 2025-09-30 | $414.15M 10-Q · filed 2025-10-29 | |
| 2025-06-30 | $406.33M 10-Q · filed 2025-08-05 | |
| 2025-03-31 | $400.00M 10-Q · filed 2025-05-08 | |
| 2024-12-31 | $394.73M 10-K · filed 2026-02-24 | |
| 2024-09-30 | $390.68M 10-Q · filed 2024-11-07 | |
| 2024-06-30 | $385.10M 10-Q · filed 2024-08-08 | |
| 2024-03-31 | $380.65M 10-Q · filed 2024-05-02 | |
| 2023-12-31 | $376.53M 10-K · filed 2025-02-26 | |
| 2023-09-30 | $374.78M 10-Q · filed 2023-11-07 | |
| 2023-06-30 | $370.04M 10-Q · filed 2023-08-08 | |
| 2023-03-31 | $363.74M 10-Q · filed 2023-05-09 | |
| 2022-12-31 | $360.15M 10-K · filed 2024-03-05 | |
| 2022-09-30 | $355.19M 10-Q · filed 2022-11-08 | |
| 2022-06-30 | $351.12M 10-Q · filed 2022-08-05 | |
| 2022-03-31 | $345.54M 10-Q · filed 2022-05-05 | |
| 2021-12-31 | $342.76M 10-K · filed 2023-03-14 | |
| 2021-09-30 | $340.21M 10-Q · filed 2021-11-04 | |
| 2021-06-30 | $336.50M 10-Q · filed 2021-08-05 | |
| 2021-03-31 | $329.60M 10-Q · filed 2021-05-06 | |
| 2020-12-31 | $326.39M 10-K · filed 2022-02-25 | |
| 2020-09-30 | $318.95M 10-Q · filed 2020-10-30 | |
| 2020-06-30 | $315.52M 10-Q · filed 2020-08-07 | |
| 2020-03-31 | $311.85M 10-Q · filed 2020-05-06 | |
| 2019-12-31 | $311.62M 10-K · filed 2021-03-01 | |
| 2019-09-30 | $307.84M 10-Q · filed 2019-11-06 | |
| 2019-06-30 | $304.82M 10-Q · filed 2019-08-06 | |
| 2019-03-31 | $300.58M 10-Q · filed 2019-05-08 | |
| 2018-12-31 | $297.32M 10-K · filed 2020-02-24 | |
| 2018-09-30 | $294.59M 10-Q · filed 2018-10-29 | |
| 2018-06-30 | $291.52M 10-Q · filed 2018-08-01 | |
| 2018-03-31 | $155.31M 10-Q · filed 2018-04-30 | |
| 2017-12-31 | $153.17M 10-K · filed 2019-02-26 | $153.17M 10-K · filed 2018-02-28 |
| 2017-09-30 | $136.05M 10-Q · filed 2017-11-01 | |
| 2017-06-30 | $134.68M 10-Q · filed 2017-08-02 | |
| 2017-03-31 | $133.44M 10-Q · filed 2017-05-04 | |
| 2016-12-31 | $132.47M 10-K · filed 2018-02-28 | |
| 2016-09-30 | $113.06M 10-Q · filed 2016-11-02 | |
| 2016-06-30 | $112.44M 10-Q · filed 2016-08-03 | |
| 2016-03-31 | $111.69M 10-Q · filed 2016-05-04 | |
| 2015-12-31 | $111.37M 10-K · filed 2017-03-01 | |
| 2015-09-30 | $110.74M 10-Q · filed 2015-11-05 | |
| 2015-06-30 | $93.10M 10-Q · filed 2015-08-06 | |
| 2015-03-31 | $92.76M 10-Q · filed 2015-05-05 | |
| 2014-12-31 | $78.68M 10-K · filed 2016-02-29 | |
| 2014-09-30 | $73.26M 10-Q · filed 2014-11-13 | |
| 2014-06-30 | $73.04M 10-Q · filed 2014-08-04 | |
| 2014-03-31 | $72.78M 10-Q · filed 2014-04-30 | |
| 2013-12-31 | $72.37M 10-K · filed 2015-03-05 | |
| 2013-09-30 | $72.24M 10-Q · filed 2013-10-30 | |
| 2013-06-30 | $55.33M 10-Q · filed 2013-08-14 | |
| 2013-03-31 | $55.17M 10-Q · filed 2013-04-30 | |
| 2012-12-31 | $54.91M 10-K · filed 2014-03-06 | |
| 2012-09-30 | $54.90M 10-Q · filed 2012-11-06 | |
| 2012-06-30 | $54.73M 10-Q · filed 2012-08-14 | |
| 2012-03-31 | $54.55M 10-Q · filed 2012-05-15 | |
| 2011-12-31 | $54.39M 10-K/A · filed 2013-08-07 | |
| 2011-09-30 | $54.14M 10-Q · filed 2011-11-14 | |
| 2011-06-30 | $13.30M 10-Q/A · filed 2011-09-09 | |
| 2010-12-31 | $9.93M 10-K · filed 2012-03-15 | $12.94M 10-Q/A · filed 2011-09-09 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| BIOLIFE SOLUTIONS INC (BLFS) | United States | $1.887B | 23.80 |
| TransMedics Group, Inc. (TMDX) | United States | $2.911B | 15.17 |
| CONMED Corp (CNMD) | United States | $1.353B | 26.72 |
| Ceribell, Inc. (CBLL) | United States | $0.916B | -11.27 |
| LivaNova PLC (LIVN) | $4.158B | 24.01 | |
| Integer Holdings Corp (ITGR) | United States | $4.289B | 25.17 |
| CapsoVision, Inc (CV) | United States | $0.310B | -12.68 |
| Electromed, Inc. (ELMD) | United States | $0.233B | 31.13 |
| EDAP TMS SA (FOCL) | $0.171B | ||
| Stereotaxis, Inc. (STXS) | United States | $0.130B | -7.53 |